$LAZ

Orszag Peter Richard sold $5.4M of LAZ

Orszag Peter Richard (CEO & Chairman) sold 125,000 shares of Lazard, Inc. (LAZ) at $43.52 ($5.44M total) on 2026-08-25 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Orszag Peter Richard
Published Aug 27, 2026, 12:51 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 27, 2026, 1:39 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LAZ
Bearish
medium confidence
Mentioned
$LAZ
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LAZBearishMed
01

Why it matters

The insider sale adds a fresh data point for traders assessing short‑term price pressure on Lazard.

02

Market read

The filing is a primary source of material insider activity, relevant for short‑term trading decisions on LAZ.

03

What to watch

Potential upcoming strategic initiatives or capital allocation plans not disclosed could mitigate the perceived negative signal.

Relevance 5/10Novelty 7/10Timing: post‑market 2026‑08‑25

Background

Form 4 filings provide the first public disclosure of insider transactions, offering timely insight into insider sentiment.

Company-level read

Ticker impact

$LAZBearishMedium confidence
Context

CEO Peter Orszag sold 125,000 shares for $5.44M via a 10b5-1 plan, reducing his stake to 260,942 shares.

Expected impact

Possible modest downside of 1-2% in the next trading session.

Evidence & confidence

Sale size is material for a mid‑cap firm and executed under a pre‑arranged plan, suggesting a neutral to slightly bearish impact.

Market effects

Minimal; the sale does not affect the broader financial advisory sector.

None; the transaction is specific to Lazard.

Low; only relevant to investors tracking Lazard.

Counterpoint

The sale follows a pre‑arranged plan and may not reflect negative outlook; investors could view it as routine liquidity management.

Key entities

  • Lazard, Inc.

    Global financial advisory and asset management firm.

  • Peter Orszag

    CEO & Chairman of Lazard, executing a 10b5‑1 sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LAZMed

BlackRock, Inc. Adds 1.83 Million Lazard Inc (LAZ) Shares -- Sto

BlackRock, Inc. acquired 1.83 million shares of Lazard Inc (LAZ) at $43.23 per share, increasing its stake to 11.20% of outstanding shares. Lazard's stock is currently trading at $41.87, with a GF Value of $46.74, suggesting modest undervaluation. The company has a market cap of $4.08 billion and operates in financial advisory and asset management.

$LAZMedAI 8/10

Lazard Stock Plunges 14% in 6 Months: Buy the Dip or Cut Your Losses?

Lazard Inc. (LAZ) stock has fallen 14.1% in six months, underperforming peers like Virtu Financial (VIRT) and Jefferies Financial (JEF). Weak earnings, high costs, and macroeconomic uncertainty weigh on its outlook. Analysts revised 2026 earnings down 10.6%, though 2027 estimates show an 83.6% increase. The company's valuation is high, with a P/B ratio of 5.3X. Management targets long-term growth but near-term challenges persist.